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ABSTRACT

Cancer is the second leading cause of death in the United States after heart disease.
Because the frequency of cancer diagnoses is correlated with life expectancy, we can
expect the rate of cancer diagnosis to increase with the increase of life expectancy.
Additionally, cancer treatments are notoriously costly and challenging due to the
heterogeneity of the cancer cell population. For these reasons, devising methods to study
the characteristics, efficiently diagnose and treat cancer is extremely important.

Warburg effect has been considered as the most unique mechanism that differ cancer
cells from normal cells. Normally, most of the healthy cells predominantly produce
energy by a low rate of glycolysis and oxidation of pyruvate in mitochondria, called
oxidative phosphorylation. In the 1920s, Otto Warburg observed that tumors uptake a
massive amount of glucose compared to its surrounding healthy tissues. Additionally,
glycolysis was continued even in the presence of oxygen, called aerobic glycolysis.
Cancer cells trend to metabolize excessive uptake of glucose and ferment to lactate
unlike normal cells, even in the presence of oxygen and fully functioning mitochondria.
This high rate of aerobic glycolysis in cancer cells is known as Warburg effect, which
has been studied extensively especially after 2000s. Cancer cells have an unusually high
rate of glycolysis and subsequently lactic acid fermentation to produce energy for cell
activities, even under aerobic conditions, a seemingly inefficient way of producing
energy.

It is recognized that cancer tumors undergo acidification due to the Warburg effect and

the overexpression of carbonic anhydrase enzymes at the surfaces of cancer cells,
making acidity a universal tumor characteristic, and following the micro calories
exchange during glycolytic fermentation. The more invasive the cancer is, the greater
the extra-cellular acidosis and heat production.

The pH (Low) Insertion Peptides comprise a novel class of pH-sensitive targeting agents
that spontaneously insert into cell membranes under acidic conditions. Therefore, the
applicability of pHLIP® peptides to tumor-targeting applications is an obvious choice
for investigation, it could be reconstructed with many different types of imaging and
therapeutic agents. The membrane associated folding mechanism of action of pHLIP is
triggered by low pH. The high concentration of proton in the low pH environment
increase the protonation of the protonatable residues in pHLIP, which increase the
overall hydrophobicity and drives the peptide into the hydrophobic core of the
membrane, where it forms transmembrane helix. The two terminus of the peptide, one
stays in the extracellular space while the other one pass through the membrane and
locates into the cytoplasm.

With the creation of SNARF-pHLIP® construct in this work, it will allow me to measure
the extra-cellular pH at the surface on the membrane of individual cancer cells. This will
provide an advantage over measuring the bulk extra-cellular pH since it will result in
higher contrast between normal, metastatic and non-metastatic cells, furthermore this
novel construct could help with cancer diagnosing. I will apply it to metastatic and nonmetastatic cancer cell lines. This will showcase that non-metastatic and metastatic cells
can be distinguished from each other quickly and easily by their individual surface pHs.

Enhanced permeability and retention (EPR) effect is how most of the approved
nanomedicinal products work though for cancer imaging and therapy. However, the
heterogenous of cancers made them impossible to universally target. Extracellular
acidity has been identified as a common property of cancerous cells, hence we can apply
pHLIP® as a novel agent to coat noisome, making it has a high uptake near cancer cells.
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PREFACE
This dissertation is written in “Manuscript” format, using the Thesis/Dissertation
template of the University of Rhode Island. There are three manuscripts included in this
dissertation, each of which comprises a chapter. The tables and figures of each
manuscript are listed under the corresponding chapter in the list of tables and figures.

The results of our studies presented in the last chapters were published in the following
papers:
1. Pereira MC, Pianella M, Wei D, Moshnikova A, Marianecci C, Carafa M,
Andreev OA & Reshetnyak YK. “pH-sensitive pHLIP® coated niosomes.”
(2017) Mol Membr Biol. doi:10.1080/09687688.2017.1342969.

The first chapter is composed of research that has been submitted for publication in
Molecular Imaging and Biology:
3. Wei D, Engelman DM, Reshetnyak YK and Andreev OA “Mapping of Acidity
at Cancer Cells Surfaces.” Manuscript submitted for publication.

We are still working on collecting data and analysis for the second chapter, the results are
in the hypothesis direction, it will be continued and published in the future.
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ABSTRACT
Solid tumors have an acidic extracellular environment, which results from the elevated
glycolytic activity of cancer cells. Cancer cells maintain neutral intracellular pH (7.2)
by transporting out protons and lactate acid. Acidity of extracellular microenvironment
in tumor, and particularly near the cancer cells surface, is high. To validate this
assumption, we recently introduced a novel approach of extracellular pH measurements
at the surface of cells by using a pH-sensitive fluorescent dye, SNARF, conjugated to a
pH Low Insertion Peptide (pHLIP® peptide), which targets plasma membranes of cells
in acidic diseased tissue. Our original approach was based on measurements of
fluorescence spectra of SNARF pHLIP. Here we present a novel pH mapping method,
which allows measurements of pH of individual cells with high spatial resolution. Novel
approach is based on the analysis of two fluorescent images of SNARF pHLIP formed
by dual view optical system where one image is recorded using 579±17 nm filter and
other image using 647±28.5 nm filter. We developed program to align images, find
ratios between images and convert ratios into pH map for individual cells. An average
pH for each cell and a pH histogram for all cells within the image are calculated. The
data obtained on several cancer cell lines grown in spheroids indicate that in absence of
glucose or in presence of deoxyglucose (non-metabolizable glucose analog) the pH at
the surface of most cells were similar and close to the pH of bulk solution. While in
presence of glucose highly metastatic cancer cells have lower surface pH than nonmetastatic cells, and both cells types showed surface pH to be lower than bulk
extracellular pH.
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INTRODUCTION
Otto Warburg discovered that cancer cells predominately use glycolysis for ATP
production even when oxygen supply is sufficient, and he also found that tumor
microenvironment is more acidic than that in normal tissues [1]. For many years the
main tool of measuring pH in tumor tissue was a needle pH meter, which is an invasive
method that damage cells and could not distinguish between intercellular and
extracellular pHs [2]. It was believed that intracellular pHi and extracellular pHe were
both acidic until it was shown that pHi is rather neutral (7.2) in both normal and cancer
cells, while pHe is an acidic in tumors in contrast to normal pHe found in healthy tissue
[3-5]. Tumor acidosis is caused mostly by the enhancement of glycolytic metabolism
and an inhibition of phosphorylation-oxidation pathway of energy production [6, 7]. To
maintain normal pHi cancer cells have to pump out protons produced during glycolysis
[8]. Membrane carbonic anhydrases are inducing further cell surface acidification by
hydrating cell-generated CO2 into HCO3- and H+ at the cancer cell membrane [7]. As
a result, it is expected that an “acidic layer” will be formed around cancer cells, and
steep proton concentration gradient might exist near the surface of cancer cells. Thus,
the cancer cells surface pH is the best measure of tumor acidity.

We recently introduced novel approach for cell surface pH measurements using pH Low
Insertion Peptide (pHLIP) conjugated with pH sensitive ratiometric fluorescent dye,
SNARF [9]. pHLIPs can target tumors and deliver imaging and therapeutic agents to
cancer cells within tumors [10-15]. pHLIPs form transmembrane helix with N-terminus
pointed outside a cell and C-terminus inserted across membrane. SNARF was
conjugated to the N-terminus of pHLIP to measure pH near the surface of cancer cells
3

in extracellular space [9]. We used spectroscopic method to record SNARF emission at
580 nm and 640 nm, calculate ratio and convert it into pH values. However, this
approach does not allow measuring of pH at a single cell level. Therefore, here we
present a new pH mapping method to measure pH of individual cells with high spatial
resolution.

MATERIALS AND METHODS
Materials
D-(+)-glucose ≥ 99.5% and 2-deoxy-D-glucose ≥ 99% were purchased from SigmaAldrich. Matrigel® growth factor reduced basement membrane matrix, phenol red-free
was obtained from Corning. The wild type (WT) pH (Low) Insertion Peptide, WTpHLIP, was synthesized with a single Lys residue near its acetylated N-terminus (AcAKEQNPIYWARYADWLFTTPLLLLDLALLVDADEGT) and purified by reversephase chromatography at the C.S.Bio. SNARF™-1 carboxylic acid, acetate,
succinimidyl ester was purchased from ThermoFisher Scientific.

Phosphate-Buffered Solutions
Phosphate-buffered solutions were prepared to obtain the pH range of 6.0-8.0 by mixing
0.5 M dibasic and monobasic solutions (J. T. Baker). The final experimental PBS
solution contained 10 mM phosphate, 150 mM NaCl (J. T. Baker), 0.2 mM MgCl2
(Sigma), and 0.2 mM CaCl2 (Sigma). Buffer solutions were sterilized by passage
through a 0.2-µm filter. The final pH for each solution was measured by dual star pH /
ISE benchtop meter with a microelectrode (Thermo Scientific™ Orion™).
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Synthesis of SNARF-pHLIP
Lys-WT and SNARF-1 were dissolved in DMF (dimethylformamide, Sigma), and
incubated at a ratio of 2:1 in 60% DMF (dimethylformamide), 30% 0.1 M PBS pH 9.0
and 10% pH 9.5 0.1 M sodium bicarbonate buffer for a final pH of 9.0. SNARF-1 was
converted to its fluorescent form after conjugation by raising the conjugation solution’s
volume by 50% with methanol and raising the solution pH to 14 with 2 M potassium
hydroxide for 1 hour. Then, pH was adjusted to pH 7.0 by adding 30% HCl. The reaction
progress was monitored by reverse phase (Zorbax SB-C18 columns, 9.4 × 250 mm 5
μm, Agilent Technology) high-performance liquid chromatography (HPLC) using a
gradient of 25−75% acetonitrile and water containing 0.05% of trifluoroacetic acid. The
concentration of each labeled peptide in buffer was determined by SNARF-1 absorption
at 548 nm, ε548=27,000 M-1 cm−1. The purity and characterization of the construct
was performed by analytical HPLC and surface-enhanced laser desorption/ionization–
TOF mass spectrometry.

Cell Lines
Human melanoma M4A4 and NM2C5 cell lines were obtained from the American
Tissue and Culture Collection (ATCC). Cells were authenticated, stored according to
supplier’s instructions, and used within 3–4 months after frozen aliquots resuscitations.
All lines were cultured in Dulbecco’s modified Eagle medium (DMEM) containing 4.5
g/L glucose and 40 mg/L sodium pyruvate supplemented with 10% FBS (Gibco), 0.1%
of 10 µg/mL ciprofloxacin⋅HCl (Cellgro, Voigt Global Distribution) in a humidified
atmosphere of 5% CO2 at 37 °C.
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Tumor Spheroids
A 2% agarose (Sigma) solution was made by dissolving in pH 7.4 PBS (Gibco). 150 µL
of the solution was pipetted into each well of a 48-well flat bottom tissue culture plate
(Celltreat). After the agarose gel had sufficiently settled (∼1 h), 150 µL of DMEM
supplemented with 10% FBS and ciprofloxacin⋅HCl was added to each well. The
covered plate was left in a humidified atmosphere at 37°C and 5% CO2 in cell culture
incubator for 24 h. Next day, the excess media was removed from the agarose layer.
NM2C5 or M4A4 cells, 10,000 cells, in 200 µL of DMEM contains 2% matrigel
(Corning) were added into each well and kept in cell culture incubator for 3-4 days to
allow formation of spheroids. Matrigel was dissolved on ice overnight and added in ice
cold DMEM at a concentration of 2.5% (to obtain final 2% once added to the wells).
Then the mixture was heated to 37°C before being combined with cells.

Imaging Tumor Spheroids
Tumor spheroids of a given cell line were incubated in 50 μL of PBS buffer, pH6.3
containing 5 μM SNARF-pHLIP and either 25 mM glucose or 50 mM deoxyglucose in
a humidified atmosphere of 5% CO2 at 37°C for 30 min. After treatment the spheroids
were washed three times in 1 mL of experimental PBS of the desired pH containing
either 25 mM glucose or 50 mM deoxy-glucose for control. Next, the spheroids were
placed into a 96 wells glass bottom dish for imaging.

The fluorescence images were recorded using Olympus IX71, an inverted
epifluorescence microscope, using FF01-531/40-25 Semrock excitation filter; a DV2
multichannel imaging system, with FF01-579/34-25 and FF01-647/57-25 Semrock
6

emission filters in left and right channels, respectively, which allowed two images to be
taken at the same time by Q-imaging Retiga-SRV CCD.

Data Analysis
For each pH point, 20 spheroids were used in total: 10 spheroids were used for
calibration, and 10 spheroids were used for cancer cell surface pH measurements. For
calibration and pH measurements glucose and deoxy-glucose were added to 5 spheroids,
respectively. 5 images were taken from different spots of each spheroid. All images
were analyzed by our program written in Matlab R2016b. The output of analysis
included a correction curve, pH map and pH histogram for the selected cells in each
image. Statistical analysis and final graphs were obtained using Origin Lab 2016.

RESULTS
To measure pH at the surface of cancer cells we used pHLIP conjugated with pH
sensitive fluorescent dye, SNARF, at the N-terminus of the peptide, which stays
exposed to the extracellular space after insertion into plasma membrane of cancer cells.
Previously we demonstrated using quenching of SNARF fluorescence by membrane
impermeable Trypan Blue that SNARF pHLIP is not taken by endocytosis, and SNARF
indeed is located in the extracellular space and reports about cell surface pH [9].
Fluorescence spectrum of SNARF exhibits two maxima at 580 nm and 640 nm, the ratio
of intensities of which correlates with pH of microenvironment. The advantage of
ratiometric method is that it does not depend on concentration of SNARF and allows to
measure pH with high accuracy. The intensities of two emission maxima can be
obtained from fluorescence spectrum recorded by linear CCD camera simultaneously in
7

the range of 570 - 700 nm, as it was done in our previous work [9]. The spectroscopic
method is accurate, however, it measures only an average intensity values from the
illuminated spot, which includes multiple cells and space between cells [9]. In this work
we developed pH mapping approach. SNARF fluorescence was excited using 531±20
nm excitation filter, and emission signal was split into two using DV2 optical system to
acquire two fluorescent images, where one image was obtained using 579±17 nm
emission filter (called 580 nm) and the other image is obtained using 647±28.5 nm
emission filter (called 640 nm). Both images are originated from the same area and
acquired simultaneously by the same CCD camera, which exclude any influence of
potential intensity fluctuations on calculated pH values. The interface of image analysis
program in Matlab is presented on Figure 1. First, correction at a pixel level is applied
in order to align two selected regions from the image (Figure 1a). The intensity values
of each pixel at the center (within the region of ±25 pixel units) of the selected 640 nm
image region are compared with the corresponding central pixels intensity values of 580
nm image region (Figure 1b). The differences in intensity between 640 nm and 580 nm
images are shown in Figure 1f. Two images are adjusted to reach minimum of the
intensity differences and align images for further processing. Intensity (Figure 1c) and
size (Figure 1d) cutoff were used to establish cell border outline (red outlines in Figure
1e). The pH mapping is obtained by calculating the averaged intensity ratio for each cell
and converting these ratios into pH values using calibration curves (Figure 1g). The pH
histogram reflects distribution of the surface pH for all selected cells (Figure 1h).

The calibration curves were obtained for NM2C5 (Figure 2a) and M4A4 (Figure 2b)
cancer cells separately. M4A4 or NM2C5 tumor spheroids were incubated in media with
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no glucose and then transferred into media containing of 50 mM of non-metabolizable
analog of glucose, deoxyglucose. The inhibition of glycolysis results in shutdown of
acid production by cells, and flux of protons. As a result, the pH at the surface of cells
became the same as in the bulk solution, which was used to calibrate fluorescence signal
with pH. We recorded numerous cells images at different buffer pH and calculated
580/640 ratio images (RM4A4 and RNM2C5) to establish calibration curves for each
cancer cell lines (Figure 2a, b):

for M4A4 cells:

𝑝𝐻 = (9.990 ± 0.111) − (5.182 ± 0.190) ∙ 𝑅𝑀4𝐴4

for NM2C5 cells: 𝑝𝐻 = (10.187 ± 0.100) − (5.257 ± 0.155) ∙ 𝑅𝑁𝑀2𝐶5

The calibrations curves are slightly different for M4A4 and NM2C5 cells, which might
be attributed to the difference in membrane protein and/or lipid compositions.

The calibration equations were used to calculate surface pH from the SNARF pHLIP
580/640 nm ratio imaging of non-metastatic cancer cell line, NM2C5, and metastatic
cancer cell line, aM4A4, in the presence of 25 mM glucose, which promotes cellular
metabolism. In the presence of glucose, both NM2C5 and M4A4 cells show lower pH
at the surface compared with the bulk extracellular pH. Furthermore, metastatic cancer
cells were slightly more acidic than non-metastatic cancer cells, especially when the pH
of media was normal or higher than pH 7.4. When the pH of media is lower than pH 6.4,
the pH at the surface of cancer cells equilibrates with bulk solution pH (Figure 2a, b).
The surface pH differences (difference in pH found in the presence of glucose and
deoxy-glucose) for each type of cancer cells are shown in Figure 2c. At normal or high
9

pH of media the metastatic cancer cells, M4A4, exhibit a significantly larger pH
difference, about 0.7 pH units, compared to the non-metastatic cancer cells, NM2C5,
pH difference of which is about 0.3 pH units (Figure 2d).

Finally, 100x magnification objective was used to image single M4A4 cells in tumor
spheroids (Figure 3). Instead of calculating the average intensity for cell, we calculated
the intensity ratios at each pixel inside a single cell to establish pH mapping. The
obtained results clearly indicate that the surface pH within a single cell is not uniform,
which might be associated with segregation of proton pumps.

DISCUSSION
In early days tumor acidity was measured mostly by microelectrodes directly inserted
into tumor tissue. It was demonstrated that tumors are acidic and it was believed at that
time that extracellular and intracellular, pHe and pHi, were both acidic [4]. However,
microelectrodes could not directly measure pH inside of a cell. Only after development
of magnetic resonance spectroscopy (MRS) methods it was found that pHi in cancer
cells is similar to or slightly more basic than that in normal cells, while pHe in tumors
was more acidic than pHe in healthy tissues [3, 5]. MRS methods are using pH sensitive
agents to measure pHe in tumors in vivo [16]. Those agents are distributed in both blood
(where pH is normal) and extracellular space. Thus, MRS provides measure of an
averaged pH in tumors [17-21]. Since cancer cells have to maintain pHi in the range of
pH 7.2 – 7.4 for normal cellular functions, they have to pump out protons and lactate,
which are produced in high amounts due to the enhancement of glycolysis [1]. The other
by-product is CO2, which freely diffuses across membrane and is converted into
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carbonic acid by membrane proteins, carbonic anhydrases (CAIX, CAXII),
overexpressed in cancer cells [22-24]. Protons create high acidity zone near the cancer
cell membrane. pH increases with distance from the cancer cells, and bulk extracellular
pH might be normal in a well perfused tumor areas, or might remain low in a poorly
perfused tumor zones. Despite on variations of bulk extracellular pH in tumors
(documented by MRS measurements) cell surface pH is much more stable parameter,
which correlates well with metastatic potential of cancer cells. Therefore, it is important
to develop tools of cell surface pH measurements to investigate tumor development and
progression. And, it is crucial for pH targeting approaches to sense acidity at the cell
surface, as pHLIP does, for targeting of imaging and therapeutic agents to all cancer
cells within tumors. In this work we introduced new method to map cell surface pH at
the level of individual cancer cells. We believe, the introduced approach can find many
applications in cancer biology studies, and it might be translated to the clinics for pH
measurements on tissue samples removed in the course of needle biopsy or surgery.
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FIGURES

Figure 1. The interface of image analysis program in Matlab is shown. Fluorescence
580 nm and 640 nm images (a) were obtained using DV2 beam splitting system and
579±17 nm and 647±28.5 nm emission filters, respectively. The area of interest is
selected by squares. Image correction (b), intensity (c) and size cutoff (d) panels of
interface are presented, which are used to establish cell border outlines shown in red (e).
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The differences in intensity values in each pixel at the center (within the region of ±25
pixels) between 640 nm and 580 nm image regions (f) were used to adjust 580 nm image
position to reach minimum of the intensity differences (achieve the smallest score) and
align images for further processing. pH map (g), where pH values are indicated by
different colors, and pH histogram (h) calculated for the selected region from (a).
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Figure 2. Calibration curves for NM2C5 (a) and M4A4 (b) cells grown in tumor
spheroids obtained by linear fit of buffer pH vs 580/640 SNARF fluorescence intensity
ratio in presence of 50 mM deoxy-glucose at various pHs of buffer. Cell surface pH (c)
measured using SANRF pHLIP in NM2C5 and M4A4 cell spheroids in the presence of
25 mM glucose at various pHs of buffer were calculated using calibration curves (a and
b) obtained for each cell line to convert 580/640 nm fluorescence ratios into pH values.
The cell surface pH differences (d) for non-metastatic NM2C5 and metastatic M4A4
cancer cells were calculated by comparing pH values obtained in the presence of deoxyglucose and glucose at different pHs of buffer.
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Figure 3. (a) Single cell was selected on the surface of M4A4 tumor spheroids and two
images were acquired using DV2 system with 580 (left) and 640 (right) nm filters. (b)
Left and right images were aligned and 580/640 nm intensities ratios were calculated
for each pixel, the ratios were converted in pH values and presented as pH map with
color scale shown on the right.
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Abstract
Warburg effect has been considered as the most unique mechanism that differ cancer
cells from normal cells. Normally, most of the healthy cells predominantly produce
energy by a low rate of glycolysis and oxidation of pyruvate in mitochondria, called
oxidative phosphorylation. In the 1920s, Otto Warburg observed that tumors uptake a
massive amount of glucose compared to its surrounding healthy tissues. Additionally,
glycolysis was continued even in the presence of oxygen, called aerobic glycolysis [1,
2]. Cancer cells trend to metabolize excessive uptake of glucose and ferment to lactate
unlike normal cells, even in the presence of oxygen and fully functioning mitochondria.
Cancer cells have an unusually high rate of glycolysis and subsequently lactic acid
fermentation to produce energy for cell activities, even under aerobic conditions, a
seemingly inefficient way of producing energy. This high rate of metabolism leads to
the metabolic chemical reactions and ions directional flows in living cells driven by
electrochemical potentials and energy-consuming pumping processes, which all
together would result in the heat production. In this research, we designed experiments
to measure heat production by cancer cells due to their metabolic activity. From the
isothermal calorimetry measurements, we estimated that HeLa cells produce about 40
times more heat per second than regular Chinese Hamster Ovarian cell. From
intracellular temperature measurements, we also observed that GFP – HeLa incubated
with glucose has a higher temperature than incubated with deoxy-glucose.
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Introduction
The metabolic chemical reactions and the various kinds of ions directional flows in
living cells driven by electrochemical potentials and energy-consuming pumping
processes is hypothesized to result in the heat production [3, 4]. Steep temperature
gradients in cells have attracted strong interest from cell biologists recently, especially
concerning the effects of local intracellular thermogenesis on the rates of chemical
reactions, the rate of the diffusion process, the speed of exocytosis [5], and so on. The
peculiarities of energy metabolism in cancer cells are imputable not only to a markedly
glycolytic phenotype, but also to some essential features, such as a heavy imbalance in
the NADH/NAD+ ratio with a marked increase of lactate and decrease of pyruvate
production [6-8]. Temperature is of fundamental importance in many cellular processes
such as cell metabolism, cell division and gene expression [5, 9, 10]. Accurate and
noninvasive monitoring of temperature changes in individual cells could thus help
clarify intricate cellular processes and develop new applications in biology and
medicine.

In a long history of the physiological studies on thermogenesis, the thermodynamic
parameters have mainly been examined for different parts of the body, tissues or organs,
as a whole [5-8]. With the development of new methods and technologies, there are
appeared some recent studies on thermogenesis at single-cell level. In this part, I will
introduce the methods that we developed for single cell heat production measurements,
progresses and some results.
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Isothermal Titration Calorimeter (ITC) for extracellular heat production
measurement
ITC is a technique used in quantitative studies of a wide variety of biomolecular
interactions. ITC is the only technique that can simultaneously determine all binding
parameters in a single experiment. A complete thermodynamic profile of the molecular
interaction, including binding constants (KD), reaction stoichiometry (n), enthalpy (∆H)
and entropy (ΔS) could be accurately calculated by measuring the heat transfer during
binding [11]. Not only given binding affinities, ITC is particularly useful as it elucidates
the mechanisms underlying molecular interactions, which leads to further optimization
of compounds and more confident decision making [12]. In our research, ITC was used
to monitor the heat production by cancer cells after injection with glucose or deoxyglucose.

ITC has been used to directly measure the heat production that is either released or
absorbed during a biomolecular binding event. It is composed of two identical cells
made of a highly efficient thermally conducting and chemically inert material such as
Hastelloy alloy or gold, surrounded by an adiabatic jacket. One of the cells is called
reference cell, which is usually filled with buffer or water; the other one is sample cell,
where the reaction take place when injecting the second component to the sample. The
microcalorimeter needs to keep these two cells at the same temperature. If there is a
difference between two cells when binding occurs, the sensor can detect the difference
in temperature and give feedback to the heaters, the heaters that making direct
connection with the cells will start compensating until the temperature in the sample cell
is the same with the reference cell. The heat exchange during the reaction, which is a
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few millionths of a degree Celsius, will be detected and measured by the output of the
heater to maintain the temperature balance.

In our ITC experiment, we loaded 5 million HeLa cells that have been starved in the
medium without glucose overnight into measuring unit, then injected glucose or deoxyglucose and monitored the heat exchange for 10 hours. All solutions in this experiment
were degassed, since it is often necessary to obtain good measurements as the presence
of gas bubbles within the sample cell will lead to abnormal data plots in the recorded
results. The entire experiment took place under computer control. As described in
Figure1, negative heat flow means the reaction is exothermic, the temperature in the
sample cell increases upon addition of glucose, which lead to the decreases for the
feedback power to the sample chamber to maintain an equal temperature between the
two chambers. As the temperature of the two chambers reach equilibrium, the heat flow
line reached a plateau. The first heat flow spike/pulse at 0 second gives the total heat
released upon glucose or deoxy-glucose injections, and mixing process. It has been
observed that a plateau was reached in 1 hour after injection of deoxy-glucose while
after glucose injection it took about 4 hours. The heat release, which is the integral of
the curve, also indicates that HeLa has more heat production with glucose injection than
with deoxy-glucose that. We estimated that single HeLa cell generates about 4 nW,
which is about 40 times higher than that for regular Chinese Hamster Ovarian cell (0.1
nW), and 13 times higher than human fibroblasts (0.3 nW).
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Green Fluorescent Protein (GFP) Anisotropy for intracellular heat production
measurement

In physics, as opposed to isotropy, anisotropy means inhomogeneity in all directions. It
is the quality of exhibiting properties being directional dependent, which implies
different values when measured along axes in different directions. Anisotropy is most
easily observed in regular lattices, in which atoms, ions, or molecules are arranged
regularly. Usually these lattices include single crystals of solid elements or compounds
[13]. In life science, fluorescence anisotropy, which is a population of fluorophores
illuminated by a linearly polarized light that re-emits partially polarized fluorescence
due to the random orientation of the molecular dipoles [14]. A strong light source is
generally required for fluorescence polarization measurements. The light wave coming
from this source can have an unlimited number of orientations. A polarization filter
transmits only light of one orientation of electric vector. Fluorophore molecule can be
considered as a linear oscillator, which would absorb light with a probability
proportional to cosine of angel between dipole vector and electric vector of excitation
light and it would emit light with probability of orientation of electric vector
proportional to the cosine of angel between emitting dipole and electric vector of emitted
light. Use another polarization filter for emission signal, the strength of the signal
changes according to the orientation of the emitted light. The emitted light that has the
same orientation as the polarized excitation filter completely passes the same orientation
emission polarized filter. The emitted light that is perpendicular to the polarized
excitation filter is completely blocked by the same filter. The anisotropy r of a light
source is defined as the ratio of polarized components:
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𝑟 =

𝐼𝑧 − 𝐼𝑦
𝐼𝑥 + 𝐼𝑦 + 𝐼𝑧

When we use two excitation polarization filters that have the perpendicular orientations,
one is in the same orientation with the polarized excitation filter, another one is
perpendicular to it, two polarized intensities that perpendicular to each other could be
detected. If the excitation polarizer is in z-axis, then the parallel emission from
fluorophore is symmetric in the same orientation, the perpendicular emission polarizer
will be in xy- plan. Statistically, we have 𝐼𝑥 = 𝐼𝑦 , as 𝐼𝑦 = 𝐼⊥, 𝐼𝑧 = 𝐼⫽ , the anisotropy
of fluorophore has become:
𝑟 =

𝐼⫽ − 𝐼⊥
𝐼⫽ + 2 𝐼⊥

To calculate the fluorescence anisotropy, we just need to measure the polarized emission
intensities that parallel and perpendicular to the polarized excitation light.
For immobilized randomly oriented dipoles anisotropy of emitted light could be 0.4 if
emission and excitation dipoles are collinear, and -0.2 if they are perpendicular.
Fluorophores in solution are very mobile and dipole can rotate during excited state and
emit at different angel, which leads to depolarization of emitted light. Depolarization of
fluorescence depends on ratio of rotational correlation time and fluorescence life time.
Rotational correlation time decreases with increase of temperature while fluorescence
life time is less sensitive to temperature. The fluorophores, which are molecular level
particles that suspended in cytoplasm, have molecular rotation [15]. The measured value
r is closely related to molecular rotation, according to Perrin’s equation:
1
1
𝜏𝐹
=
(1 + )
𝑟
𝑟0
𝜏𝑅
Where 𝑟0 is a constant called “limiting anisotropy”, 𝜏𝐹 is another constant called
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fluorescence lifetime and 𝜏𝑅 is rotational correlation time, while 𝜏𝑅 depends on the
temperature 𝑇, the viscosity 𝜼(𝑇), and the hydrodynamic volume 𝑉. 𝜏𝐹 does not.
According to Debye-Stoke-Einstein equation:
𝜏𝑅 =

𝑉 𝜼(𝑇)
𝑘𝐵 𝑇

Temperature could be measured by using fluorescence anisotropy. When the
temperature increases, the molecular rotation of the fluorophores is accelerated, they
move faster in a given amount of time. Faster movement means that the polarization of
the light is conserved for a shorter time, which means that an increase in temperature
results in lower polarization signal. Consequently, an increase in temperature leads to a
decrease of the fluorescence polarization anisotropy. This technique has a lot of
advantages compare to other methods, the ratiometric measurement is absolute
intensities independent, common issues like photobleaching and fluorophore migration
could be eliminated. This method is also noninvasive for cells, which provides more
accurate and optimistic results.

In our previous study, we constructed optical system and developed the software to
create and analyze the fluorescence anisotropy images of cells, single molecules and
nanoparticles. The system includes the inverted microscope (Olympus IX71), two
calcite prisms (CPs) inserted in the excitation and emission optical paths, and a CCD
camera (Retiga-SRV, Q-imaging Co.). The excitation light was passed through the
pinhole diaphragm, split by CP into two orthogonally polarized beams and focused by
objective into two spots. The emission CP splits the fluorescence image of each spot
into two images formed by horizontally and vertically polarized emission lights. The
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CCD camera simultaneously records four images so the fluctuation in intensity of
excitation light does not affect anisotropy values and, most importantly, that two
polarized components corresponds exactly to the same state of a sample. We are using
this system to study the “blinking” effect of quantum dots, binding of fluorescently
labeled molecules to proteins, DNA, RNA in cells.

In this research, we used a new optical system that almost identical to the cell surface
pH measurement. Instead of measuring the two excitation peaks from the fluorescent
dye, SNARF, we are capturing the polarized fluorescent signals at two perpendicular
directions from green fluorescent protein (GFP). The first direction is parallel to the
incident polarized light’s direction, the second one is perpendicular to the incident
polarization. GFP is one of the most widely studied and used proteins that extracted
from jellyfish, which is a fluorophore that re-emits partially polarized fluorescence due
to the random orientation of the molecular dipoles. We used GFP transfected HeLa in
our experiments. Since GFP was expressed in the cytoplasm of HeLa cells, the
temperature that measured in the experiment would be the local temperature of
intracellular space. Temperature imaging technique for HeLa – GFP combines high
spatial resolution and fast read-out with full biocompatibility.

In the optical system, a vertically polarized filter was installed between the microscope
and the lamp, to turn the incident light into polarized light to the randomly oriented GFP
inside of the cells, only those molecules that are oriented properly in the polarized plane
can absorb light, become excited, and subsequently emit polarized light in a plane. On
the side, the protein fluorescence signal goes into the beam splitter that contains a
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vertical and a horizontal polarizer on each side, and split the incident beam into two
identical beams for each side. One beam will pass through the vertically polarized filter,
which is parallel to the incident light, the intensity is 𝐼⫽ . The identical split beam will
pass through the horizontal polarized filter, which is perpendicular to the incident light,
this intensity is 𝐼⊥ . The signals were recorded by the CCD camera in the same image on
the right and left side, as a result, the emitted light was measured in both the vertical and
horizontal planes. To check the orientation of the polarizers, an external polarizer was
used under bright field with a calibration slide, when the external polarizer was rotated,
the intensities will change based on the angle between the polarizers. When the external
polarizer rotates to the vertical orientation, the vertically signal will completely pass the
filter, while the horizontally signal completely being blocked by the filter (Figure 2),
indicating the polarizers are in the correct experimental orientation.

G factor is the instrument sensitivity ratio towards vertically and horizontally polarized
light [16]. In fluorescence anisotropy measurements, the G factor is not related to
properties of the sample but is purely an experimental correction for the polarization
bias of the detection system. For accurate measurement, G factor has to be considered
in the equation.
𝑟 =

𝐼⫽ − 𝐺 𝐼⊥
𝐼⫽ + 2 𝐺 𝐼⊥

G factor is also measured by exciting the sample using vertically polarized light and
subsequently measuring the vertically and horizontally polarized components of the
emission intensity, each for the same period of time. Since there is no difference
between the numbers of photons coming towards the vertical and horizontal channels
27

from the sample, G factor is calculated as the ratio between the measured total intensities
in each channel. For anisotropy imaging we need to do correction all image pixels. To
calculate the G factor, fluorescein was used as correction sample. As the fluorescence
anisotropy for fluorescein is close to zero due to the complete random orientation of the
small molecule and very low rotational correlation time (<1 ns), 𝑖⫽ and 𝑖⊥ should be
equals to each other theoretically, the intensity difference in the two orientations will be
caused by the optical system. (Figure 3) By measuring 𝑖⫽ and 𝑖⊥ , G factor could be
calculated by 𝐺 =

𝑖⫽
𝑖⊥

.

To apply the detection system correction to the samples, the equation can be converted
to:
𝐼⫽
𝐼⊥
𝑖⫽
𝐼
−
𝐼
⫽
𝑖⫽ − 𝑖⊥
𝐼⫽ − 𝐺 𝐼⊥
𝑖⊥ ⊥
𝑟 =
=
=
𝑖⫽
𝐼⫽
𝐼⫽ + 2 𝐺 𝐼⊥
𝐼⊥
𝐼⫽ + 2 𝑖 𝐼⊥
+
2
𝑖⫽
𝑖⊥
⊥
Thus, an image calculation for both sides of the image at the same time, cell image
divided by fluorescein solution image would apply the G factor to the sample (Figure
4). Once the G factor has been applied to the cell image, the image can be processed by
the further modified Matlab code for anisotropy imaging. The procedures are identical
to pH imaging, including load the image, select sections from two sides of the image,
apply the correction for the selected sections to align the regions, subtract the lowest
intensity value in the regions as background to the cells, contour the cells based on
intensity and area cutoff, calculate the fluorescence protein anisotropy for each
contoured cell, plot anisotropy map and histogram for each image with all the selected
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cells (Figure 5).

During the experiment, two dishes with 50,000 HeLa-GFP cells were grow in 300uL
DMEM with high glucose in a collagen coated glass bottom microwell dish for one day,
the medium was changed to DMEM without glucose to starve the cells overnight in the
incubator, which is a humidified atmosphere of 5% CO2 and 95% air at 37°C. On the
third day, cells were washed three times with pH 7.4 PBS contains physiological level
ions, then stayed in 300uL experimental PBS buffer contains 25Mm glucose, and
another dish with 50mM deoxy-glucose as comparison. After 30 minutes in room
temperature to reach temperature equilibrium, the cells in the dishes were used for
imaging. The fluorescence images were recorded through Olympus IX71, an inverted
epifluorescence microscope, using a vertical polarization filter and GFP-3035B-OMFZERO Semrock filter set; a DV2 multichannel imaging system, with vertical polarized
and horizontal polarized filter in left and right channels respectively, which allows
images that have different information on the two sides taken at the same time by
Qimaging Retiga-SRV CCD. Fluorescence images of the samples were taken by using
Q-capture Pro 7. 10, images for each situation was taken and analyzed through Matlab
2016b. Statistic and result graphs were constructed by Origin Lab 2016.

In the result, anisotropy values were indicated in y axis (Figure 6). There is a clear
difference of 0.00836 in anisotropy between samples incubated with glucose and deoxyglucose. Cells incubated with glucose have a lower anisotropy, indicating that these
cells have an overall higher temperature. The result is in agreement with what we have
assumed from the beginning and the result we got from ITC experiment.
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Since a higher temperature for cancer cells incubated with glucose has been confirmed,
and the anisotropy difference is 0.00836. What are the temperatures for the cells in each
case? To determine the temperature, a calibration experiment between measured
anisotropy and local temperature around cells was performed. The same amount of
HeLa-GFP were prepared in the same procedures, starved overnight in DMEM without
glucose and incubated in 3mL PBS with same concentration of deoxy-glucose the next
day, so it would be possible to measure the buffer temperature in the dish with EXTECH
EsayViewTM 10 thermometer. The temperature of the sample was controlled by Tokai
Hit stage top incubator from 20°C to 40°C. Images were taken 20 minutes after the stage
temperature have reached setting, the local temperature of cells were determined by the
reading of thermometer for each image. After calculating the anisotropy value in each
image at different temperatures, an equation of fluorescence protein anisotropy and cell
temperature will be acquired. Thus, the cell temperature could be determined by
knowing the anisotropy. The temperature was controlled from 22.5°C to 38.5°C, and
the measured anisotropy was from 0.23 – 0.15, with a 0.08 anisotropy unit difference.
An estimation of 1°C corresponds to 0.005 anisotropy unit, thus, the estimated
temperature difference between cells incubated with glucose and deoxy-glucose is about
1.6°C.
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FIGURES

Figure 1. Heat production from HeLa cells detected by ITC. The first heat flow
spike/pulse at 0 second gives the total heat exchanged in the glucose/deoxy-glucose
injection, which is the heat released when mixing two liquids together. Deoxy-glucose
injection takes about 1 hour to reach equilibrium and glucose injection takes about 4
hours. The heat release, which is the integral of the curve, indicating HeLa cells
release more heat production with glucose injection.
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Figure 2. Optical system polarization. When the external polarizer rotates to the
vertical orientation, the vertically signal will completely pass the filter (right side),
while the horizontally signal completely being blocked by the filter (left side).
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Figure 3. Fluorescent image of fluorescein as correction to the system. As the fluorescence
protein anisotropy for fluorescein is zero due to the complete random orientation of the
molecule. By applying this correction to the images, G factor and the uneven intensity
distribution from lamp will be eliminated.
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Figure 4. Processed HeLa-GFP image for anisotropy calculation. The original images were
devided by the G factor image, and the black regions on the sides were cropped in ImageJ for
better Matlab processing. Parallel intensity comes from the right side, and perpendicular
intensity comes from the left side of the image.
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Figure 5. Image analysis and outputs. a. The interface of image analysis program created by
Matlab. b. Differences in intensity value between the center of selected perpendicular region
and ±25 pixels units from the center of selected parallel region. The correction distance was
applied to the selected parallel region by using the location of smallest score pixel. c. Anisotropy
map for the selected cells in a., anisotropy values are indicated by different colors for each cell.
d. Anisotropy histogram for the selected cells in a..
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Figure 6. HeLa-GFP anisotropy result. The anisotropy for HeLa-GFP incubated with glucose
has a lower value than incubated with deoxy-glucose, indicating that HeLa-GFP has a higher
temperature with glucose incubation.
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Abstract
Nanomedicine is becoming very popular over conventional methods due to the ability
to tune physico-chemical properties of nanovectors, which are used for encapsulation
of therapeutic and diagnostic agents. However, the success of nanomedicine primarily
relies on how specifically and efficiently nanocarriers can target pathological sites to
minimize undesirable side effects and enhance therapeutic efficacy. Here, we introduce
a novel class of targeted nano drug delivery system, which can be used as an effective
nano-theranostic for cancer. We formulated pH-sensitive niosomes (80-90 nm in
diameter) using non-ionic surfactants Span20 (43-45 mol%), cholesterol (50 mol%) and
5 mol% of pH (Low) Insertion Peptide (pHLIP) conjugated with DSPE lipids (DSPEpHLIP) or hydrophobic fluorescent dye, pyrene, (Pyr-pHLIP). pHLIP in coating of
niosomes was used as an acidity sensitive targeting moiety. We have demonstrated that
pHLIP coated niosomes sense the extracellular acidity of cancerous cells. Intravenous
injection of fluorescently labeled (R18) pHLIP-coated niosomes into mice bearing
tumors showed significant accumulation in tumors with minimal targeting of kidney,
liver and muscles. Tumor-targeting niosomes coated with pHLIP exhibited 2-3 times
higher tumor uptake compared to the non-targeted niosomes coated with PEG polymer.
Long circulation time and uniform bio-distribution throughout the entire tumor make
pHLIP-coated niosomes to be an attractive novel delivery system.
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Introduction
Most of the currently approved nanomedicinal products for cancer imaging and therapy
are non-targeted nanovectors that accumulate in the tumor tissues purely through the
enhanced permeability and retention (EPR) effect (Dawidczyk et al., 2014). It is nearly
impossible to find a universal targeting moiety for cancers as they are heterogeneous
(Stingl and Caldas, 2007, Weigelt et al., 2005). At the same time, extracellular acidity
has been identified as a general property of cancerous cells and especially the most
aggressive ones (Stubbs et al., 2000, Calorini et al., 2012). Family of pH (Low) Insertion
Peptides (pHLIP® peptides) are under development as novel agents, which target tumor
acidity (Andreev et al., 2009, Weerakkody et al., 2013). The peptides sense pH at the
surface of cancer cells, where it is the lowest (Anderson et al., 2016), and insert into
cellular membranes (Reshetnyak et al., 2006, Reshetnyak et al., 2007, Reshetnyak et al.,
2008, Andreev et al., 2010). Nanocarriers decorated with pHLIPs are biocompatible,
can target tumor and demonstrate enhanced cellular uptake by cancer cells (Du et al.,
2014, Wijesinghe et al., 2013, Yao et al., 2013b, Arachchige et al., 2015, Yao et al.,
2013a). In addition to pHLIP-coated nanoparticles, nanocarriers containing pHsensitive polymers and lipids were known for decades (Chu et al., 1990, Subbarao et al.,
1987, Karanth and Murthy, 2007, Lee et al., 1998).

In this study we introduced pHLIP-coated niosomes. Niosomes are self-assembled
bilayer vesicles analogous to liposomes, comprised of surfactants of Span®, Tween®
or Brij® series (Rajera et al., 2011). Similar to liposomes, niosomes are used to
encapsulate both hydrophilic and lipophilic drugs. At the same time, non-ionic
surfactant vesicles, niosomes, are cheaper in production, have longer shelf lives
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compared to liposomes, and bilayer fluidity and microviscosity could be easily
modulated (Moghassemi and Hadjizadeh, 2014, Marianecci et al., 2014, Lohumi, 2012,
Karim et al., 2010). Sorbitan esters (Spans®) are FDA approved for use in food
processing and pharmaceuticals (Cottrell and van Peij, 2004). They are safe,
amphiphilic compounds derived from sorbitol (i.e., a synthetic sweetener). Span20
mostly consists of a fully saturated short alkyl chain (lauryl - C12). The single carbon
bonds in Span20 allow the alkyl chain to pack tightly, resulting in the smallest and stable
niosomes, oppose to the niosomes consisting of longer chain surfactants, Spans40-80
(Lo et al., 2010, Hao et al., 2002, Israelachvili et al., 1980). Vesicles prepared by Spanseries surfactants have been reported to be viable drug carriers for different diseases and
different routes of administration(Ghanbarzadeh et al., 2015, Balakrishnan et al., 2009,
Sahoo et al., 2014, Liu et al., 2017, Ammar et al., 2011, Guinedi et al., 2005, Hunter et
al., 1988, Jadon et al., 2009, Pardakhty et al., 2007). In this study we introduced novel
formulations, pHLIP-coated niosomes, comprised of Span20 surfactant and cholesterol.

Materials and Methods
Materials
Sorbitan monolaurate (Span20); cholesterol ≥ 99%; N-(2-Hydroxyethyl)piperazine-N′(2-ethanesulfonic acid) (HEPES) ≥ 99.5% and N-(1-Pyrenyl)maleimide (Pyr-maleimide)
were

purchased

from

Sigma-Aldrich.

1,2-dioleoyl-sn-glycero-3-

phosphoethanolamine-N-[4-(p-maleimidophenyl)butyramide] sodium salt (DSPEmaleimide)

and

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-

[carboxy(polyethylene glycol)-2000] ammonium salt

(DSPE-PEG(2000)) were

obtained from Avanti Polar Lipids. Octadecyl Rhodamine B chloride (R18) was
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purchased from Thermo Fisher Scientific. The wild type (WT) pH (Low) Insertion
Peptide: ACEQNPIYWARYADWLFTTPLLLLDLALLVDADEGT was prepared by
solid-phase peptide synthesis and purified at the C.S. Bio. All other chemicals used in
the study were of the highest purity and all solvents were of spectroscopic grade. Water
was purified through a Millipore Milli-Q system.

Synthesis of DSPE-pHLIP and Pyr-pHLIP
pHLIP was conjugated with Pyr-maleimide or DSPE-maleimide in methanol. 5 mg of
peptide dissolved in 250 µL methanol (blown with argon) and Pyr-maleimide or DSPEmaleimide (from 9.9 mM stock solution) dissolved in chloroform was mixed at a molar
ratio 1:1. Reaction mixture was kept at room temperature for about 2-6 hours until the
conjugation was completed. The Pyr-pHLIP product formation was monitored by the
reversed phase (Zorbax SB-C18 columns, 4.6 × 250 mm 5 μm, Agilent Technology)
high-performance liquid chromatography (RP-HPLC) using a gradient from 25-75%
acetonitrile in water containing 0.05% trifluoroacetic acid (TFA). The Pyr-pHLIP
product was characterized by SELDI-TOF mass spectrometry (Pyr-pHLIP expected
MW 4409.0, found 4401.7, Figure S1). The concentration of Pyr-pHLIP conjugate was
determined by absorbance using the molar extinction coefficient for Pyr:

339=40,000

M−1·cm−1. The reaction progress in conjugation of DSPE with pHLIP was monitored
by the RP-HPLC using a gradient from 25-80% acetonitrile in water containing 0.05%
TFA by monitoring a decrease of peak corresponding to the unlabeled pHLIP in the
reaction mixture. The concentration of DSPE-pHLIP conjugate was determined by
absorbance using the molar extinction coefficient for pHLIP:
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280=13,940 M−1·cm−1.

Niosomes preparation
10 mM stock solutions of Span20 and cholesterol were prepared by dissolving the
products in chloroform and methanol mixture of 3:1 (v/v). pHLIP-coated niosomes were
prepared by mixing solutions of the 43 mol% of Span20, 50 mol% of cholesterol, 5 mol%
of DSPE-pHLIP or Pyr-pHLIP and 2 mol% of R18. PEG-coated niasomes were
prepared by mixing solutions of the 43 mol% of Span20, 50 mol% of cholesterol, 5 mol%
of DSPE-PEG and 2 mol% of R18. Some preparations of niasomes used for
fluorescence spectroscopy measurements, hemolysis and plasma stability studies
contained no R18 and comprised of 45 mol% of Span20, 50 mol% of cholesterol, 5 mol%
of Pyr-pHLIP, or DSPE-pHLIP, or DSPE-PEG. Solutions containing all components
were evaporated in the flask covered with aluminum foil for 1 hour on rotary evaporator
at 60°C producing an even thin film, followed by additional 1 hour evaporation under
the high vacuum to remove traces of organic solvents. The layers were hydrated in 2
mL of preheated for 60°C 10 mM PBS or HEPES buffer solutions, pH 7.4 containing
137 mM NaCl, 2.7 mM KCl and 1 mM CaCl2. To disrupt large particles and obtain
monodisperse solution of nanoparticles we employed both sonication and extrusion. The
sonication and extrusion protocols were optimized varying power and duration of
sonication, as well as adjusting extrusion approach. According to the optimized protocol
niosome solution was sonicated using the probe sonicator VirTis (VirSonic 100) for
approximately 5 minutes at 60°C at output power of 8-10 Watts, followed by
consequential extrusion (31 times) using 200 nm, 100 nm and 50 nm filters. Niosome
solution was sterilized by filtering through 0.2 μm filter. The concentration was
calculated by measuring absorbance of R18 at 546 nm (ε546=104,126 M−1 cm−1) or
pHLIP at 280 nm (ε280=13,940 M−1 cm−1) of the niosomes dissolved in methanol.
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Niosomes were stored at 4°C.

Size and Zeta potential measurements
The size distribution of niosomes was measured by dynamic light scattering (DLS)
using a Zetasizer Nano ZS (Malvern) instrument and a nanoparticle tracking system,
Nanosight (NS300, Malvern). The zeta (

) potential was measured on a Zetasizer Nano

ZS instrument using folded capillary cells from Malvern.

Fluorescence measurements
Steady-state fluorescence measurements were carried out under a temperature control
at 25

C on a PC1 spectrofluorometer (ISS, Inc.). The concentration of the pyrene was

12.5 µM. Pyrene fluorescence was excited at 333 nm and recorded in the range of 350500 nm. The polarizers in the excitation and emission paths were set at the “magic”
angle (54.7o from the vertical orientation) and vertically (0o), respectively.

Cryo-electron microscopy
Niosome solution (5 μL droplet) was spread on a Lacey formar/carbon electron
microscopy grid and preserved in a frozen-hydrated state by a rapid freezing in liquid
ethane. The vitrification process was performed using FEI Vitrobot system with the
setting of a single blot of 3 sec, an offset of 1, and drain and waiting time of 1 sec.
Transmission electron microscopy (TEM) (JEOL 2100) with an accelerating voltage of
200 kV at magnifications in the range of 10,000x to 150,000x was used to image
niasomes to establish the shape, size, and homogeneity of the particles. Size histograms
were fitted with a Gauss function.
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Cell lines
Lung carcinoma A549 and mouse mammary 4T1 cell lines were obtained from
American Type Culture Collection (ATCC). Cells were authenticated, stored according
to the supplier’s instructions, and used within 3 4 months after frozen aliquots
resuscitations. Cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM)
and Roswell Park Memorial Institute Medium (RPMI) supplemented with 10% fetal
bovine serum (FBS), 0.1% of 10 μg/mL of ciprofloxacin (Cipro) in a humidified
atmosphere of 5% CO2 and 95% air at 37°C.

Cell proliferation assay
A549 and 4T1 cells were seeded in 96 well-plates (~3,000 cells per well) at pH 7.4.
The following day, cells were treated for 2 hours with increasing concentrations of
pHLIP-coated niosomes (0, 10, 50, 100, 250, 500 and 1000 μM of Span20) in serum
free DMEM media at pH 7.4, followed by addition of an equal volume of medium with
20% (v/v) FBS. In another experiment, after 2 hours of cells treatment with pHLIPcoated niosomes, the solution was replaced by media containing 10% FBS. Cells were
grown for 3 days until non-treated cells in control reached 80 90% confluence. Cell
viability was assessed by the colorimetric reagent (CellTiter 96 AQueousOne Solution
Assay,

Promega)

of

the

MTS

(3-(4,5-dimethylthiazol-2-yl)-5-(3-

carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay, which was added
for 1 hour to cells followed by measuring absorbance at 490 nm. All samples were
prepared in triplicate. Each experiment was repeated several times.
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Hemolysis assay
Single donor human whole blood was purchased from Innovative Research. Red blood
cells (RBCs) were collected by centrifugation of whole blood at 2000 rpm for 10
minutes followed by washing three times with Dulbecco’s PBS (DPBS) and resuspended in DPBS at a concentration of 7.5% (v:v). Varying concentrations of
niosomes (from 50 µM up to 400 µM) in 10 mM HEPES buffer, pH 7.4 containing
137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2 were added to RBCs to form 5% RBC
suspension. The resultant mixtures were incubated at 37°C for 2 hours and then
centrifuged at 2000 rpm for 10 min. The hemolysis was assessed by the release of
hemoglobin, which was monitored by measuring of absorbance at 450 nm. 10 mM
HEPES buffer, pH 7.4 containing 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2 and DPBS
were used as negative controls. As positive controls, which result in 100% lysis of RBCs,
we used i) water and ii) 10% of Triton X-100. The percentage of hemolysis was
calculated as follows:

% 𝐻𝑒𝑚𝑜𝑙𝑦𝑠𝑖𝑠 = 100 ∙

𝑂𝐷𝑇𝑒𝑠𝑡 − 𝑂𝐷𝑁𝐶
𝑂𝐷𝑃𝐶 − 𝑂𝐷𝑁𝐶

where, ODTest, ODNC, and ODPC are the optical density reading (absorbance) values
of the test sample, negative control and positive control, respectively. The assay was
performed in triplicate on niosomes with and without R18.

Stability in plasma
Plasma was separated from the single donor human whole blood by centrifugation of
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whole blood at 2000 rpm for 10 minutes and collecting of supernatant. Varying
concentrations of niosomes (from 50 µM up to 400 µM) in 10 mM HEPES buffer, pH
7.4 containing 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2 were added to plasma and
incubated at 37°C. The stability of niosomes was assessed by monitoring size of
niosomes measured using a nanoparticle tracking system, Nanosight (NS300, Malvern)
before mixing with plasma and at 0, 2 and 24 hours after the treatment with plasma.

Cellular uptake of niosomes
A549 and 4T1 cells (~500,000 cells) in suspension were treated with 500 µM R18
labelled pHLIP-coated niosomes at pH 7.8 and pH 5.5 for about 1 hour at 37°C in serum
free DMEM media. We used DMEM containing no sodium bicarbonate and adjusted
pH by HCl or NaOH. After incubation period, cells were pelleted by centrifugation
(2500 rpm, 2.5 min) at room temperature. The supernatant was removed and the cell
pellet was re-suspended in 1 mL of fresh PBS pH 7.4 and centrifuged for the second
time. The second cell pellet was re-suspended in PBS pH 7.4 with or without addition
of Trypan Blue solution (Sigma-Aldrich). The 20 μL of the cell suspension solution was
loaded into a counting chamber. The cellular uptake of fluorescent niosomes was
assessed by counting of fluorescent cells using Nexcelom cellometer at 525 nm
excitation and 595 nm emission channels.

Fluorescence microscopy
In separate experiment, A549 and 4T1 cells (~500,000 cells) in suspension were treated
with 500 µM R18 labelled pHLIP-coated niosomes at pH 6.4 (or normal pH 7.4) for 1
hour at 37°C serum free media and followed by the described above steps of cell
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washing. After washing, the cell pellet was re-suspended and cells were seeded in glass
bottom collagen coated cell dishes (MatTek). The phase contrast and fluorescence
images from cells were recorded at 0, 4 and 24 hours under an inverted epi-fluorescence
microscope (Olympus IX71) using a 20x and 40x objective lenses.

Tumor mouse model
All animal studies were conducted according to the animal protocol AN07-01-015
approved by the Institutional Animal Care and Use Committee at the University of
Rhode Island, in compliance with the principles and procedures outlined by NIH for the
Care and Use of Animals. 4T1 mammary tumors were established by subcutaneous
injection of 4T1 cells (1 ×106 cells/mL, 0.1 mL/flank) in the right flank of adult female
BALB/c mice (about 20 25 g weight) obtained from Envigo RMS, Inc. For this study,
34 mice were used including controls.

Ex vivo fluorescence imaging
When tumors reached 6 8 mm in diameter different constructs of niosomes containing
2 mol% of fluorescent R18 were given as a single tail vein injection (100 µL of 50 µM
of R18). Animals were euthanized at 4, 24 and 48 hours post-injection. Necropsy was
performed immediately after euthanization. The Supplementary Tables S1 and S2
contain information about the number of animals used for each fluorescently-labeled
niosomes for each time point. Tumors, kidneys, liver and muscles were collected for
imaging on a FX Kodak in-vivo image station connected to the Andor CCD. The
imaging was performed using excitation and emission filters with a band of
transmittance at 540±20 nm and 605±20 nm, respectively. The mean fluorescence
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intensities of tumor and organs were calculated using ImageJ software.

Imaging of tumor sections
Frozen tumor tissues were sectioned at a thickness of 5 μm using a Vibratome UltraPro
5000 Cryostat. Sections were mounted on microscope slides, dried in air, and washed
with deionized water. Tumor sections mounted on microscopic slides were directly
incubated with 1 mM DAPI solution in PBS at 37°C for about 10 minutes and washed
with PBS solution to remove excess of the dye. Frozen tumor sections with R18
contained pHLIP-coated niosomes were analyzed without further processing using
Zeiss LSM 700 confocal module under DAPI and Rhodamine channels using a 20x
objective lens. Following fluorescence imaging, the adjacent sections were then stained
with hematoxylin and eosin (H&E) and imaged under microscope.

Results
We introduced two formulations of pHLIP coated niosomes. In both cases the major
components of niosome content was Span20 (varied in the range of 43 45 mol%) and
cholesterol (50 mol%), and in some niosome formulations we also used fluorescent R18
(0-2 mol%). pHLIP was conjugated either with DSPE lipids (DSPE-pHLIP) or
hydrophobic fluorescent dye, pyrene, (Pyr-pHLIP) and introduced into niosomes at
amount of 5 mol%. These formulations represent two different approaches for
introducing pHLIP into niosome coating: i) pHLIP conjugated with the lipid headgroup
as it was done previously (Wijesinghe et al., 2013) and ii) pHLIP conjugated to various
hydrophobic molecules, such as pyrene, which have high affinity to membrane and can
intercalate into bilayer. There is an advantage of using pyrene over DSPE lipids, since
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i) progression of conjugation reaction of pHLIP with pyrene is easy to monitor by HPLC
and mass-spectrometry; ii) incorporation of Pyr-pHLIP into niosomes could be assessed
by measuring changes of pyrene fluorescence (see below); and iii) pyrene could be used
for intercalation into bilayers of various thicknesses.

The cryo-TEM imaging confirmed unilamellar structure of pHLIP-coated niosomes
(Figure 1a, b). The multiple cryo-TEM images were analyzed to plot size-distribution
histograms, which were fitted by Gauss functions (Figure S2). The mean and standard
deviations of Gaussian distributions for DSPE-pHLIP and Pyr-pHLIP coated niosomes
were established to be 65.2±15.3 nm and 52.2±10.1 nm, respectively (Table 1). The
hydrodynamic diameter of DSPE-pHLIP and Pyr-pHLIP coated niosomes in solution
were 89.7±7.1 nm and 72.6±3.3 nm, respectively. The zeta potential of DSPE-pHLIP
and Pyr-pHLIP coated niosomes was -35.4 mV and -31.3 mV, respectively. When PyrpHLIP was incorporated into niosomes the fluorescence spectra of pyrene was altered
compared to the pyrene emission in methanol (the niosome formulation used for
fluorescence measurements did not contain fluorescent R18) (Figure 1c). It was
observed appearance of the characteristic excimer fluorescence at 440-500 nm, which
is indicative of the stacking of pyrene rings within the bilayer of niosomes.

We investigated shelf lifetime of pHLIP coated niosomes. The formulations were kept
in buffer solution of pH 7.4 refrigerated at 4°C for a month. The size of particles
remained unchanged in solution during 30 days, while the values of zeta potential
decreased on about 40% (from negative 30

35 mV to negative 47

53 mV) (Figure

S3). The changes of zeta potential, which were not associated with changes of particle
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size, might be attributed to the oxidation of the components of Span20 mixture forming
negatively charged species and enhancing an overall negative charge of niosomes (de
Sousa Lobato et al., 2013, Kishore et al., 2011, Smith, 1981, Kerwin, 2008).

The cytotoxicity of the pHLIP-coated niosomes was tested on murine 4T1 mammary
cancer cells and human lung A549 carcinoma cells. The data indicate that DSPE-pHLIP
and Pyr-pHLIP niosomes do not show toxicity for cells. The pH-dependent cellular
uptake of the fluorescent pHLIP-coated niosomes containing 2 mol% of R18 was
assessed by quantifying rhodamine fluorescence taken by cells. Cells were treated with
R18 containing niosomes at pH 7.8 and pH 5.5 for 1 hour. We choose to treat cells with
constructs at pH7.8, which is slightly above than normal physiological pH7.4, since it
was shown that pH at the surface of cancer cells, especially highly metastatic cancer
cells such as 4T1, is lower even when pH of media is normal (Anderson et al., 2016).
We also choose to treat cells with constructs at pH5.5, which is slightly lower than mean
pH established at the surface of cancer cells within tumors, pH6.0, (Anderson et al.,
2016) with main goal to enhance difference in cellular uptake of niosomes in this model
experiment. The fluorescent signal from the cells treated with niosomes was analyzed
using cellometer (Figure 2). We also used cell impermeable dye, Trypan Blue, to quench
fluorescent signal outside of cells or at the outer leaflet of lipid bilayer of plasma
membrane to prove that fluorescent signal is associated with cellular uptake of niosomes.
It is known that Trypan Blue is used to quench fluorescence in the range of 580 620 nm
(Nuutila and Lilius, 2005). The uptake of the fluorescent niosomes coated with both
DSPE-pHLIP and Pyr-pHLIP by 4T1 and A549 cancer cells was from 2 to 9 times
higher at low pH compared to the uptake at treatment pH of 7.8 (established with high
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statistical significance, p-levels determined by the two-tailed unpaired Student’s t-test
were less than 0.0001). Addition of Trypan Blue to cells led to the quenching of
rhodamine fluorescence. More detailed information about cellular fluorescence after the
treatment with niosomes is presented in Figure S4.

Next, we investigated distribution of the fluorescent niosomes within A549 and 4T1
cancer cells. Cells were treated with R18 fluorescent niosomes at low pH (pH6.4) for 1
hour, followed by washing, seeding cells in glass bottom collagen coated cell dishes and
imaging. The fluorescent signal of DSPE-pHLIP and Pyr-pHLIP coated niosomes in
A549 cells (Figure 3) and 4T1 cells (Figure S5) were distributed through cells, most
probably in endosomes and lysosomes. The data confirmed pH-dependent cellular
uptake of pHLIP-coated niosomes.

Finally, our goal was to investigate tumor targeting and distribution of pHLIP-coated
niosomes, which we compared with the control niosomes coated with PEG polymer that
accumulate in tumors due to the EPR effect. Before proceeding to animal studies we
investigate stability of pHLIP and PEG coated niosome formulations in plasma, and
calculated percentage of hemolysis. RBCs and plasma were separated from human
blood samples. RBCs were treated with two sets of increasing concentrations of pHLIP
and PEG coated niosomes with and without R18 for 2 hours at 37°C. The lysis of RBCs
was less than 1% in the case of use of DSPE-pHLIP and Pyr-pHLIP coated niosomes
and less than 2% for DSPE-PEG coated niosomes. Also, stability of pHLIP and PEG
coated niosomes with and without R18 were investigated for 24 hours in plasma
separated from the blood. The size of all niosome formulations (DSPE-pHLIP, Pyr53

pHLIP and DSPE-PEG) was not altered indicating on their stability in blood.

The tumor targeting of the fluorescent R18 containing DSPE-pHLIP and Pyr-pHLIP
coated niosomes were investigated in mice. Fluorescent niosomes were given as a single
tail vein injection, animals were euthanized at different time points post-injection (4, 24
and 48 hours). Main organs were collected, cut in half and imaged (Figure 4 and Table
S1). At 24 hours we observed peak in tumor uptake of the fluorescent niosomes. The
mean tumor to muscle ratio within 48 hours was found to be 4.9±1.3 and 6.8±1.4 for
DSPE-pHLIP and Pyr-pHLIP coated niosomes, respectively. The signal in kidney was
minimal, with some accumulation of the constructs in liver. Uptake of pHLIP-coated
niosomes by tumor, muscle, kidney and liver at 24 hours post-injection was compared
with the uptake of PEG-coated niosomes. Figure 5a shows representative images of
tumor and organs obtained from mice injected with different constructs and Figure 5b
(and Table S2) reflects quantitative uptake of the constructs by the tumors and organs.
Tumor-targeting niosomes coated with pHLIP exhibited 2.1-2.7 times higher tumor
uptake compared to the non-targeted niosomes coated with PEG polymer. Figure 6
demonstrates cellular distribution of fluorescent signal within the tumor mass. The
sections were obtained from the center of the tumors. The fluorescence is associated
with cellular structures and no nuclear staining was observed as in the case of
experiments on cultured cells.

Discussion
The targeted delivery of nanomaterials is one of the most important aspects of successful
development of nanotechnology and translation of nanomaterials to the clinics. Various
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approaches are tested with moderate success. Our approach is based on targeting of
tumor acidity by utilizing ability of pHLIPs to sense pH at the surface of cells. Acidosis
is a general property of tumor microenvironment associated with tumor development
and progressions (Fang et al., 2008, Gillies et al., 2008, Vander Heiden et al., 2009).
Moreover, acidity is linked to other pathological states, such as ischemia, atherosclerosis,
stroke (Rajamäki et al., 2013, Koo et al., 1993, Mizock and Falk, 1992). It was shown
that nanoparticles coated with pHLIP promote targeting and cellular uptake of these
nanoparticles (Wijesinghe et al., 2013, Yao et al., 2013b, Yao et al., 2013a, Wei et al.,
2017, Janic et al., 2016, Tian et al., 2017, Emmetiere et al., Han et al., 2013, Yu et al.,
2016, Yu et al., 2015). Previously, we demonstrated that pHLIP-coated liposomes
capable to fuse with cellular membranes and promote delivery hydrophobic cargo
molecules to cellular membranes, and hydrophilic payloads to cytoplasm of cancer cells
(Yao et al., 2013b). In this work we tested surfactant- and cholesterol-based niosomes.
The pHLIP-coated niosomes were smaller in size and more stable compared to the
pHLIP-coated liposomes. pHLIP-coated niosomes demonstrated pH-dependent cellular
uptake and excellent tumor targeting. Control non-targeted PEG-coated niosomes
exhibited 2-3 times less tumor accumulation. Targeting of acidic tumors occurs due to
the ability of pHLIPs to insert into cellular membranes in environment of low
extracellular pH. Thus, at low pH, pHLIPs behave as fusogenic peptides, which bring
the niosome membrane in close contact to the cellular membrane. There are two main
possibilities of pHLIP-coated niosome’s cellular entry. Either pHLIP-coated niosomes
might fuse directly with the plasma membrane of cancer cells in environment of low pH
and/or niosomes can be taken up into the cell via endocytotic pathways, more favorably,
via micropinocytosis due simultaneous insertions of multiple pHLIPs into the cellular
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membrane. Niosomes, which are internalized into cell via endocytosis might fuse with
the endosomal membrane at low pH. In either case, niosomes carrying lipophilic and/or
hydrophilic drugs can effectively enter into the cells in a pH-dependent manner.

The pHLIP-coated liposomes and niosomes follow a closely similar mechanism utilized
by viruses and pathogenic organisms to enter into a cell. In contrast to liposomes,
niosomes are smaller in size, they demonstrate prolong shelf life, very good tumor
targeting and distribution within tumor, and their manufacturing cost is lower. On other
hand, niosome’s encapsulation capacity is lower and different combinations of
surfactants are needed for entrapment of various hydrophobic molecules within their
bilayer to preserve overall stability of nano-vesicles. Different formulations might find
utility for different therapeutic purposes.
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TABLES
Table 1. The center of Gauss distribution (DTEM) and the standard deviation obtained
after fitting of histograms of niosome’s diameter distributions (shown on Figure S2)
calculated by analyzing cryo-TEM images. The mean hydrodynamic diameter (Dh), the
zeta potential ( ) and the polydispersity index (PDI) were obtained from the dynamic
light scattering measurements performed on niosomes in HEPES buffer at pH 7.4.
DSPE-pHLIP and Pyr-pHLIP (5 mol%) coated Span20 (45 mol%) and cholesterol (50
mol%) niosomes were used.

Construct

DTEM, nm

Dh, nm

, mV

PDI

DSPE-pHLIP

65.2 ± 15.3

89.7 ± 7.1

-35.4 ± 2.3

0.19 ± 0.01

Pyr-pHLIP

52.2 ± 10.1

72.6 ± 3.3

-31.3 ± 1.7

0.25 ± 0.01
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FIGURES

Figure 1. Cryogenic TEM image of the a) DSPE-pHLIP (5 mol%) and b) Pyr-pHLIP
(5 mol%) coated Span20 (45 mol%) and cholesterol (50 mol%) niosomes. The images
are obtained at 25,000x magnification. c) The fluorescence spectra of Pyr-pHLIP
measured in methanol and Pyr-pHLIP incorporated in niosomes.
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Figure 2. Normalized uptake of DSPE-pHLIP (5 mol%) and Pyr-pHLIP (5 mol%) coated
Span20 (43 mol%) and cholesterol (50 mol%) niosomes containing 2 mol% of fluorescent R18
by 4T1 mammary (a) and A549 lung (b) cancer cells at pH 7.8 and pH 5.5 before (magenta
columns) and after (gray columns) treatment with Trypan blue. The fluorescent signals were
normalized by the rhodamine fluorescence intensity of 4T1 cells at pH 7.8 treated with DSPEpHLIP before addition of Trypan blue. Statistically significant differences were determined by
two-tailed unpaired Student’s t-test, only statistically non-significant differences are indicated
(ns means p-level > 0.05), all other differences in cellular uptake calculated at different pHs, as
well as before and after Trypan Blue addition are statistically significant (p-level is less than
0.0001 in each case). The distribution of fluorescent signal in cells is presented in Figure S4.
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Figure 3. Uptake and cellular distribution of a-d) DSPE-pHLIP (5 mol%) and e-h) Pyr69

pHLIP (5 mol%) coated Span20 (43 mol%) and cholesterol (50 mol%) niosomes
containing 2 mol% of fluorescent R18 by A549 lung cancer cells. Cells were treated
with fluorescence niosomes at pH 6.4 for 1 hour, followed by washing, seeding cells in
glass bottom collagen coated cell dishes and imaging at next day. Fluorescence (a, b, e,
f) and phase contrast (c, d, g, h) images were obtained using 20x (a, c, e, g) and 40x (b,
d, f, h) magnification objective lenses.
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Figure 4. Time-dependent distribution of DSPE-pHLIP and Pyr-pHLIP (5 mol%),
Span20 (43 mol%), cholesterol (50 mol%) and R18 (2 mol%) niosomes in a) tumor, b)
muscle, c) kidney and d) liver at 4, 24 and 48 hours after single I.V. administration of
the constructs. Tumor/Muscle (T/M), Tumor/Kidney (T/K) and Tumor/Liver (T/L) ratio
calculated for DSPE-pHLIP (e) and Pyr-pHLIP (f) niasomes are shown. The values of
mean surface fluorescence intensity of R18 in tissue and organs are presented in Table
S1.
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Figure 5. a) The representative rhodamine fluorescence images and b) mean surface
fluorescence of tumor (cut in half), muscle, kidney (cut in half) and liver obtained by ex
vivo imaging after collection of organs and tissues 24 hours after I.V. administration of
pHLIP and PEG coated niosomes are shown (the autofluorescence signal is subtracted).
The color coded fluorescent images shown on panel a are obtained at the same settings
of the imaging instrument, the same exposure time (15 sec), and all of them were
processed exactly the same way. Control means organs collected from the mouse with
no injection of fluorescent niosomes, and it represents level of auto fluorescence signals
in tissue. The values of mean surface fluorescence intensity of R18 in tissue and organs
are presented in Table S2.
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Figure 6. Distribution of R18 fluorescent signal in tumor sections obtained at 24 hours
after I.V. injection of a-d) DSPE-pHLIP (5 mol%) and e-h) Pyr-pHLIP (5 mol%) coated
Span20 (43 mol%), cholesterol (50 mol%) and R18 (2 mol%) niosomes. The rhodamine
fluorescence (a, e), cell nucleus stained with DAPI (b, f), the overlay of rhodamine and
DAPI fluorescence (c, g), and adjacent HE stained sections from the same tumor (d, h)
are shown.
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Table S1. The mean and standard error values of the surface fluorescence
intensity of R18 in tissue and organs at different time points after single I.V.
administration of the DSPE-pHLIP or Pyr-pHLIP (5 mol%), Span20 (43
mol%), cholesterol (50 mol%) and R18 (2 mol%) niosomes. The
autofluorescence signal, which was in the range of 200-250 was subtracted.

Tumor

Muscle

Kidney

Liver

Time

DSPE-pHLIP
n=3

Pyr-pHLIP
n=3

4h

447 ± 84

498 ± 232

24 h

1870 ± 153

2409 ± 334

48 h

1401 ± 209

1562 ± 194

4h

76 ± 34

94 ± 44

24 h

337 ± 40

297 ± 7

48 h

410 ± 80

223 ± 35

4h

134 ± 34

207 ± 55

24 h

370 ± 60

255 ± 22

48 h

384 ± 54

225 ± 20

4h

446 ± 133

417 ± 154

24 h

1020 ± 225

893 ± 195

48 h

1343 ± 388

482 ± 52
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Table S2. The mean and standard error values of the surface fluorescence
intensity of R18 in tissue and organs at 24 hours after single I.V.
administration of different formulations of niosomes: DSPE-PEG, DSPEpHLIP or Pyr-pHLIP (5 mol%), Span20 (43 mol%), cholesterol (50 mol%)
and R18 (2 mol%) niosomes.

DSPE-PEG
n=4

DSPE-pHLIP
n=3

Pyr-pHLIP
n=3

Tumor

889 ± 191

1870 ± 153

2409 ± 334

Muscle

173 ± 38

337 ± 40

297 ± 7

Kidney

187 ± 43

370 ± 60

255 ± 22

Liver

343 ± 97

1020 ± 225

893 ± 195
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Figures

Figure S1. The SELDI-TOF mass spectrum of Pyr-pHLIP.
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Figure S2. The size histograms of the DSPE-pHLIP and Pyr-pHLIP
containing niosomes obtained after analyzing multiple cryo-TEM images.
The red lines demonstrate fittings by Gauss functions.
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Figure S3. The results of stability study of DSPE-pHLIP and Pyr-pHLIP (5
mol%), Span20 (43 mol%), cholesterol (50 mol%) and R18 (2 mol%)
niosomes in HEPES buffer in a course of 30 days (niosomes were kept
refrigerated at 4°C). The changes of mean hydrodynamic diameter and Zeta
potential are presented.
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Figure S4. Fluorescent uptake of DSPE-pHLIP or Pyr-pHLIP (5 mol%),
Span20 (43 mol%) and cholesterol (50 mol%) niosomes containing 2 mol%
of fluorescent R18 by 4T1 mammary and A549 lung cancer cells at pH 7.8
and pH 5.5 before and after treatment with Trypan blue. The cellular uptake
of fluorescent niosomes was assessed by counting of fluorescent cells using
cellometer at 525 nm excitation and 595 nm emission channels.
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Figure S5. Uptake and cellular distribution of a-d) DSPE-pHLIP (5 mol%)
and e-h) Pyr-pHLIP (5 mol%) coated Span20 (43 mol%) and cholesterol (50
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mol%) niosomes containing 2 mol% of fluorescent R18 by 4T1 lung cancer
cells. Cells were treated with fluorescence niosomes at pH 6.4 for 1 hour,
followed by washing, seeding cells in glass bottom collagen coated cell
dishes and imaging at next day. Fluorescence (a, b, e, f) and phase contrast
(c, d, g, h) images were obtained using 20x (a, c, e, g) and 40x (b, d, f, h)
magnification objective lenses.
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